Sector News Jazz Pharmaceuticals to Buy GW Pharmaceuticals for $7.2B by Sophia Vida February 06, 2021 One of the biggest announcements out of the marijuana space this month has been that Jazz Pharmaceuticals has agreed to buy GW Pharmaceuticals for a staggering $7.2 billion. As Wall Street learned the news, shares of GWPH stock...
Featured Canopy Growth Sues GW Pharmaceuticals Over Infringement by Sophia Vida December 25, 2020 One of Canada's top marijuana producers, Canopy Growth Corp., is taking Britain-based GW Pharmaceuticals to court in the U.S. According to Canopy Growth, GW Pharmaceuticals has infringed upon their intellectual property. In a c...
Science related (Medical) First FDA Approved Marijuana-Derived Epilepsy Drug Sees Stellar Sales by Sophia Vida August 07, 2019 Gw Pharmaceuticals is the company behind Epidiolex, the first FDA approved epilepsy drug that is cannabis derived. The company announced on Tuesday that sales of the drug had more than doubled compared to the previous quarter. ...
Spotlight Stock The U.S. FDA Approves First Marijuana-Based Medicine by Sophia Vida June 26, 2018 The Food and Drug Administration made history on Monday by approving the nation's very first drug derived from cannabis called Epidiolex. GW Pharmaceutical's Epidiolex is made of CBD, a component of marijuana that provides no h...
Spotlight Stock FDA May Soon Approve a Prescription Drug Made From Marijuana by Sophia Vida June 21, 2018 GW Pharmaceuticals may soon see its epilepsy drug, Epidiolex, approved by the Food & Drug Administration to be a prescription drug. The drug is made from a component of cannabis that doesn't give the user the "high," and is...